Traws Pharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Traws Pharma Inc.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
/ 
Frequently asked questions
To buy Traws Pharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Traws Pharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Traws Pharma Inc. is TRAW:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Traws Pharma Inc. has its primary listing on NASDAQ. You can trade Traws Pharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Traws Pharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Traws Pharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Traws Pharma Inc..